- Filed
- Nov 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 210.54M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 219.89M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 218.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 206.91M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 206.47M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $55.41M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$46.81M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $194.37M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $314.87M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $128.8M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $216.14M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $84.08M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $104.71M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $96.84M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$387.89M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$421.59M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$451.93M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$475.93M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$468.56M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$475.61M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$476.17M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$455.53M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $190.24M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $160.38M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $834.31M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $966.35M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $355.68M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $421.97M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $446.42M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $490.42M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.06 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.08 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.07 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.30 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.06 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.09 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.07 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.30 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $83.01M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $252.87M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $65.1M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $185.84M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $44.6M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $125.26M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $41.08M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $125.2M |
| Net Income | Q3 2025 · Sep 30, 2025 | $12.9M |
| Net Income | Q3 2025 · Sep 30, 2025 | $18.02M |
| Net Income | Q3 2025 · Jun 30, 2025 | $5.09M |
| Net Income | Q3 2025 · Mar 31, 2025 | $32K |
| Net Income | Q3 2025 · Sep 30, 2024 | −$14.03M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$62.09M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$12.67M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$35.38M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $29.59M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $80.6M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $7.69M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.97M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.19M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $9.55M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $3.21M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $6.18M |